Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state

References

• Alonzo DE, Zhang GG, Zhou D, et al. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res 2010;27:608–18
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2003;50:47–60
   Web of Science ®Google Scholar
• Six K, Verreck G, Peeters J, et al. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J Pharm Sci 2004;93:124–31
   PubMed Web of Science ®Google Scholar
• Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004;93:563–70
   PubMed Web of Science ®Google Scholar
• Vaughn JM, McConville JT, Crisp MT, et al. Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev Ind Pharm 2006;32:559–67
   PubMed Web of Science ®Google Scholar
• Okonogi S, Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech 2006;7:E148–53
   Google Scholar
• Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 2012;64:480–95
   PubMed Web of Science ®Google Scholar
• Zhang J, Bunker M, Parker A, et al. The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis. Int J Pharm 2011;414:210–17
   PubMed Web of Science ®Google Scholar
• Muela S, Escalera B, Peña MA, Bustamante P. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents. Int J Pharm 2010;384:93–9
   PubMed Web of Science ®Google Scholar
• Yin LF, Huang SJ, Zhu CL, et al. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm 2012;38:1371–80
   PubMed Web of Science ®Google Scholar
• Suknuntha K, Jones DS, Tantishaiyakul V. Properties of felodipine-poly(vinylpyrrolidone) solid dispersion films and the impact of solvents. ScienceAsia 2012;38:188–95
   Web of Science ®Google Scholar
• Bertram U, Bernard MC, Haensler J, et al. In situ gelling nasal inserts for influenza vaccine delivery. Drug Dev Ind Pharm 2010;36:581–93
   PubMed Web of Science ®Google Scholar
• Biswal S, Sahoo J, Murthy PN, et al. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech 2008;9:563–70
   PubMed Web of Science ®Google Scholar
• Elgindy N, Elkhodairy K, Molokhia A, Elzoghby A. Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions. Drug Dev Ind Pharm 2011;37:754–64
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343:228–37
   PubMed Web of Science ®Google Scholar
• Wei CC, Ge ZQ. Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs). Drug Dev Ind Pharm 2012;38:1084–9
   PubMed Web of Science ®Google Scholar
• Ghosh I, Snyder J, Vippagunta R, et al. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder. Int J Pharm 2011;419:12–19
   PubMed Web of Science ®Google Scholar
• Deng W, Majumdar S, Singh A, et al. Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion. Drug Dev Ind Pharm 2013;39:290–8
   PubMed Web of Science ®Google Scholar
• Baboota S, Dhaliwal M, Kohli K. Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note. AAPS PharmSciTech 2005;6:E83–90
   PubMed Web of Science ®Google Scholar
• Borghetti GS, Pinto AP, Lula IS, et al. Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm 2011;37:886–93
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–8
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Yoshioka S, Aso Y, Kojima S. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharm Sci 2004;93:2710–17
   PubMed Web of Science ®Google Scholar
• Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 2001;12:261–9
   PubMed Web of Science ®Google Scholar
• Aso Y, Yoshioka S, Zhang J, Zografi G. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by (13)C-NMR relaxation time. Chem Pharm Bull 2002;50:822–6
   PubMed Web of Science ®Google Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493–9
   PubMed Web of Science ®Google Scholar
• Hsieh YL, Ilevbare GA, Van Eerdenbrugh B, et al. pH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties. Pharm Res 2012;29:2738–53
   PubMed Web of Science ®Google Scholar
• Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res 2004;21:1762–9
   PubMed Web of Science ®Google Scholar
• Tran PH, Tran TT, Lee KH, et al. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility. Expert Opin Drug Deliv 2010;7:647–61
   PubMed Web of Science ®Google Scholar
• Khougaz K, Clas SD. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. J Pharm Sci 2000;89:1325–34
   PubMed Web of Science ®Google Scholar
• Brewster ME, Vandecruys R, Peeters J, et al. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci 2008;34:94–103
   PubMed Web of Science ®Google Scholar
• Brewster ME, Vandecruys R, Verreck G, Peeters, J. Supersaturating drug delivery systems: effect of hydrophilic cyclodextrins and other excipients on the formation and stabilization of supersaturated drug solutions. Pharmazie 2008;63:217–20
   PubMed Web of Science ®Google Scholar
• Alonzo DE, Gao Y, Zhou D, et al. Dissolution and precipitation behavior of amorphous solid dispersions. J Pharm Sci 2011;100:3316–31
   PubMed Web of Science ®Google Scholar
• Kestur, US, Lynne, S, Taylor, LS. Role of polymer chemistry in influencing crystal growth rates from amorphous felodipine. CrystEngComm 2010;12:2390–7
   Web of Science ®Google Scholar